These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 31209785)

  • 1. Association of the Polygenic Risk Score with the Incidence Risk of Parkinson's Disease and Cerebrospinal Fluid α-Synuclein in a Chinese Cohort.
    Li WW; Fan DY; Shen YY; Zhou FY; Chen Y; Wang YR; Yang H; Mei J; Li L; Xu ZQ; Wang YJ
    Neurotox Res; 2019 Oct; 36(3):515-522. PubMed ID: 31209785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Polygenic Risk Score with Age at Onset and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease in a Chinese Cohort.
    Li WW; Wang Z; Fan DY; Shen YY; Chen DW; Li HY; Li L; Yang H; Liu YH; Bu XL; Jin WS; Zeng F; Xu ZQ; Yu JT; Chen LY; Wang YJ
    Neurosci Bull; 2020 Jul; 36(7):696-704. PubMed ID: 32072450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinson disease polygenic risk score is associated with Parkinson disease status and age at onset but not with alpha-synuclein cerebrospinal fluid levels.
    Ibanez L; Dube U; Saef B; Budde J; Black K; Medvedeva A; Del-Aguila JL; Davis AA; Perlmutter JS; Harari O; Benitez BA; Cruchaga C
    BMC Neurol; 2017 Nov; 17(1):198. PubMed ID: 29141588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of Parkinson's Disease Risk Based on Genetic Profile and Established Risk Factors.
    Chairta PP; Hadjisavvas A; Georgiou AN; Loizidou MA; Yiangou K; Demetriou CA; Christou YP; Pantziaris M; Michailidou K; Zamba-Papanicolaou E
    Genes (Basel); 2021 Aug; 12(8):. PubMed ID: 34440451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of risk loci and a polygenic risk score for lung cancer: a large-scale prospective cohort study in Chinese populations.
    Dai J; Lv J; Zhu M; Wang Y; Qin N; Ma H; He YQ; Zhang R; Tan W; Fan J; Wang T; Zheng H; Sun Q; Wang L; Huang M; Ge Z; Yu C; Guo Y; Wang TM; Wang J; Xu L; Wu W; Chen L; Bian Z; Walters R; Millwood IY; Li XZ; Wang X; Hung RJ; Christiani DC; Chen H; Wang M; Wang C; Jiang Y; Chen K; Chen Z; Jin G; Wu T; Lin D; Hu Z; Amos CI; Wu C; Wei Q; Jia WH; Li L; Shen H
    Lancet Respir Med; 2019 Oct; 7(10):881-891. PubMed ID: 31326317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validity and Prognostic Value of a Polygenic Risk Score for Parkinson's Disease.
    Koch S; Laabs BH; Kasten M; Vollstedt EJ; Becktepe J; Brüggemann N; Franke A; Krämer UM; Kuhlenbäumer G; Lieb W; Mollenhauer B; Neis M; Trenkwalder C; Schäffer E; Usnich T; Wittig M; Klein C; König IR; Lohmann K; Krawczak M; Caliebe A
    Genes (Basel); 2021 Nov; 12(12):. PubMed ID: 34946808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-synuclein gene polymorphism affects risk of dementia in Han Chinese with Parkinson's disease.
    Zheng J; Zang Q; Hu F; Wei H; Ma J; Xu Y
    Neurosci Lett; 2019 Jul; 706():146-150. PubMed ID: 31102707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association analysis and polygenic risk score evaluation of 38 GWAS-identified Loci in a Chinese population with Parkinson's disease.
    Zheng R; Qiao S; Chen Y; Jin C; Fang Y; Lin Z; Xue N; Yan Y; Gu L; Gao T; Tian J; Yan Y; Yin X; Pu J; Zhang B
    Neurosci Lett; 2021 Sep; 762():136150. PubMed ID: 34352340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polygenic determinants of Parkinson's disease in a Chinese population.
    Guo JF; Li K; Yu RL; Sun QY; Wang L; Yao LY; Hu YC; Lv ZY; Luo LZ; Shen L; Jiang H; Yan XX; Pan Q; Xia K; Tang BS
    Neurobiol Aging; 2015 Apr; 36(4):1765.e1-1765.e6. PubMed ID: 25623333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of LAG3 genetic variation with an increased risk of PD in Chinese female population.
    Guo W; Zhou M; Qiu J; Lin Y; Chen X; Huang S; Mo M; Liu H; Peng G; Zhu X; Xu P
    J Neuroinflammation; 2019 Dec; 16(1):270. PubMed ID: 31847878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of low-pass genome sequencing in polygenic risk score calculation for Parkinson's disease.
    Kim S; Shin JY; Kwon NJ; Kim CU; Kim C; Lee CS; Seo JS
    Hum Genomics; 2021 Aug; 15(1):58. PubMed ID: 34454617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polygenic risk prediction and SNCA haplotype analysis in a Latino Parkinson's disease cohort.
    Loesch DP; Horimoto ARVR; Sarihan EI; Inca-Martinez M; Mason E; Cornejo-Olivas M; Torres L; Mazzetti P; Cosentino C; Sarapura-Castro E; Rivera-Valdivia A; Medina AC; Dieguez E; Raggio V; Lescano A; Tumas V; Borges V; Ferraz HB; Rieder CR; Schumacher-Schuh A; Santos-Lobato BL; Velez-Pardo C; Jimenez-Del-Rio M; Lopera F; Moreno S; Chana-Cuevas P; Fernandez W; Arboleda G; Arboleda H; Arboleda-Bustos CE; Yearout D; Zabetian CP; ; Thornton TA; Mata IF; O'Connor TD;
    Parkinsonism Relat Disord; 2022 Sep; 102():7-15. PubMed ID: 35917738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polygenic Risk Score Reveals Genetic Heterogeneity of Alzheimer's Disease between the Chinese and European Populations.
    Li F; Xie S; Cui J; Li Y; Li T; Wang Y; Jia J
    J Prev Alzheimers Dis; 2024; 11(3):701-709. PubMed ID: 38706286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GWAS-based polygenic risk scoring for predicting cerebral artery dissection in the Chinese population.
    Zhang S; Zhu D; Wu Z; Yang S; Liu Y; Kang X; Chen X; Zhu Z; Dong Q; Suo C; Han X
    BMC Neurol; 2024 Jul; 24(1):258. PubMed ID: 39054468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial and autophagy-lysosomal pathway polygenic risk scores predict Parkinson's disease.
    Dehestani M; Liu H; Sreelatha AAK; Schulte C; Bansal V; Gasser T
    Mol Cell Neurosci; 2022 Jul; 121():103751. PubMed ID: 35710056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Polygenic Risk Score With Cognitive Decline and Motor Progression in Parkinson Disease.
    Paul KC; Schulz J; Bronstein JM; Lill CM; Ritz BR
    JAMA Neurol; 2018 Mar; 75(3):360-366. PubMed ID: 29340614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced α-synuclein levels in cerebrospinal fluid in Parkinson's disease are unrelated to clinical and imaging measures of disease severity.
    van Dijk KD; Bidinosti M; Weiss A; Raijmakers P; Berendse HW; van de Berg WD
    Eur J Neurol; 2014 Mar; 21(3):388-94. PubMed ID: 23631635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polygenic risk of Parkinson disease is correlated with disease age at onset.
    Escott-Price V; ; Nalls MA; Morris HR; Lubbe S; Brice A; Gasser T; Heutink P; Wood NW; Hardy J; Singleton AB; Williams NM;
    Ann Neurol; 2015 Apr; 77(4):582-91. PubMed ID: 25773351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SNCA rs356182 variant increases risk of sporadic Parkinson's disease in ethnic Chinese.
    Cheng L; Wang L; Li NN; Yu WJ; Sun XY; Li JY; Zhou D; Peng R
    J Neurol Sci; 2016 Sep; 368():231-4. PubMed ID: 27538639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of polymorphism in rs2736990 of the α-synuclein gene with Parkinson's disease in a Chinese population.
    Pan F; Ding H; Dong H; Ye M; Liu W; Cui G; Chen J; Wu Y; Wang H; Dai X; Shi H; Ding X
    Neurol India; 2013; 61(4):360-4. PubMed ID: 24005725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.